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OSPATIO-TEMPORAL EXPRESSION ANALYSIS OF THE CALCIUM-
BINDING PROTEIN CALUMENIN IN THE RODENT BRAIN
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Abstract—Calumenin is a Ca2-binding protein that belongs
to the CREC superfamily. It contains six EF-hand domains
that exhibit a low affinity for Ca2 as well as an endoplasmic
reticulum retention signal. Calumenin exhibits a broad and
relatively high expression in various brain regions during
development as demonstrated by in situ hybridization. Signal
intensity of calumenin is highest during the early develop-
ment and then declines over time to reach a relatively low
expression in adult animals. Immunohistochemistry indi-
cates that at the P0 stage, calumenin expression is most
abundant in migrating neurons in the zones around the lat-
eral ventricle. In the brain of adult animals, it is expressed in
various glial and neuronal cell types, including immature
neurons in subgranular zone of hippocampal dentate gyrus.
At the subcellular level, calumenin is identified in punctuate
and diffuse distribution mostly in somatic regions where it
co-localizes with endoplasmic reticulum (ER) and partially
Golgi apparatus. Upon subcellular fractionation, calumenin is
enriched in fractions containing membranes and is only
weakly present in soluble fractions. This study points to a
possible important role of calumenin in migration and differ-
entiation of neurons, and/or in Ca2 signaling between glial
ells and neurons.
2011 IBRO. Published by Elsevier Ltd.
ey words: calcium-binding protein, cellular and subcellular
istribution, calcium signaling, brain development, progeni-
or cells, glial cells.
Calumenin belongs to the CREC family of Ca2-binding pro-
eins, together with reticulocalbin, reticulocalbin-3, ERC-55,
rocalbin, Cab45, and its splice variant Cab45b (Honoré and
orum, 2000; Honoré, 2009). Calumenin contains six EF-
and helix-loop-helix motifs with low affinity for Ca2 and
*Corresponding author. Tel: 43-1-40160-34050; fax: 43-1-40160-
934053.
E-mail address: werner.sieghart@meduniwien.ac.at (W. Sieghart).
Abbreviations: BCA, bicinchoninic acid; bp, base pair; CREC, Cab45,
reticulocalbin, ERC-55, calumenin; DAPI, 4’,6-diamidino-2-phenylin-
dole; DIV, day in vitro; ER, endoplasmic reticulum; GFAP, glial fibrillary
acidic protein; GFP, green fluorescent protein; HEK, human embryonic
kidney; IHC, immunohistochemistry; PBS, phosphate buffered saline;
PSA-NCAM, poly-sialylated neural cell adhesion molecule; PSD-95,
post-synaptic density protein 95; SDS-PAGE, sodium dodecyl sulfate
pen access under CC BY-NC-ND license.polyacrylamide gel electrophoresis; SGZ, subgranular zone; SV2, syn-
aptic vesicle protein 2.
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Open access under CC BY-NC-ND liarbors an endo(sarco)plasmic reticulum (ER) HDEF reten-
ion signal located at its C-terminus (Yabe et al., 1997; Vorum
t al., 1998; Honoré and Vorum, 2000; Honoré, 2009). This
ignal has a lower efficiency for ER retention as compared
ith the well studied KDEL sequence, explaining why calu-
enin was not only described to participate in the secretory
athway as other CREC family members, but is also found
xtracellularly in cultured human fibroblasts (Vorum et al.,
999; Honoré, 2009). Previous studies have demonstrated
xpression and distribution of calumenin in non-neuronal tis-
ues; however, there are no reports describing the possible
xpression of calumenin in the rodent CNS so far.
Neuronal Ca2-binding proteins exert effects on a va-
riety of important physiological functions, such as activa-
tion of transcription factors, neuronal growth and survival,
neurotransmitter release, channel and receptor regulation,
and synaptic plasticity (Burgoyne, 2007; Chaumont et al.,
2008; Amici et al., 2009). The importance of Ca2 signal-
ing in glia has also been well documented. It is believed to
be a form of glial excitability, enabling glial cells to integrate
extracellular signals, communicate with each other, and
exchange information with neurons (Verkhratsky, 1997;
Metea and Newman, 2006). Like in other cells, ER Ca2-
storage and -release in brain cells contribute crucially to
Ca2 signals, while ER Ca2-binding proteins provide a
igh capacity buffering mechanism, which results in the
owering of the concentration of free Ca2 in the ER (Koch,
1990; Verkhratsky, 2004, 2005). It has been previously
described that calumenin is abundant in ER of diverse
non-neuronal cell types (Yabe et al., 1997; Tyedmers et
al., 2005; Sahoo and Kim, 2008, 2010; Sahoo et al., 2009).
However, a possible localization of calumenin in the neu-
ronal or glial ER has not been confirmed so far.
Calumenin was also described in functional associa-
tion with the cytoskeleton where it is translocated from the
organelle-containing membrane fraction to the cytosol
upon mitotic arrest and during late apoptosis in HeLa cells,
treated with the tubulin-depolymerizing drug taxol (Bull et
al., 2010). Additionally, extracellular calumenin appears to
have an autocrine and/or paracrine modulating effect on
organization of the actin cytoskeleton (Ostergaard et al.,
2006). Whether calumenin shows cytoplasmic and/or ex-
tracellular localization in the CNS and whether it plays a
role in any of the essential cytoskeletal functions in neu-
rons (Schaar and McConnell, 2005; Hotulainen and
Hoogenraad, 2010; Svitkina et al., 2010), including neuro-
nal growth, migration, synaptogenesis, and synaptic plas-
ticity, remains to be elucidated.
As a basis for further investigations on putative func-
tions of calumenin in the brain, this study provides the first
cense.
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M. Vasiljevic et al. / Neuroscience 202 (2012) 29–4130comprehensive spatio-temporal characterization of calu-
menin expression in the CNS.
EXPERIMENTAL PROCEDURES
All the chemicals were purchased from Sigma-Aldrich, St. Louis,
MO, USA, or from Invitrogen, San Diego, CA, USA, unless other-
wise stated.
In situ hybridization
For in situ hybridization, an 827 bp long fragment of the calumenin
sequence (BP 1529–2355) was amplified from the whole mouse
rain cDNA library (a gift from Han Kyu Lee, ZMNH), and the
esulting PCR product was cloned into pBluescript KS (-) vector
Stratagene, Santa Clara, CA, USA) using EcoRI and XhoI restric-
ion sites. The correct sequence of the insert was confirmed by
equencing. Radioactively labeled RNA probes were prepared
sing the MAXIscript in vitro transcription kit (Ambion, Austin, TX,
SA) in the presence of 35S-UTP. Probes were purified with
robeQuant sephadex G-50 microcolumns (Amersham, Bucking-
amshire, UK). In situ hybridization was performed as previously
escribed (Fehr et al., 1987). Three independent experiments with
hree sets of animals for each time point were used. The sense
ranscription product served as a negative control.
Extraction of proteins
All the animals were provided by the Animal Facility of University
Clinics “Eppendorf” in Hamburg, or by the Department of Animal
Care and Genetics—Himberg, Medical University of Vienna.
Buffers were supplemented with Complete Mini Protease in-
hibitor cocktail (Roche, Mannheim, Germany). Preparation of
membranes from different organs was performed using IM-Ac
buffer (20 mM HEPES, 100 mM K-acetate, 40 mM KCl, 5 mM
EGTA, 5 mM MgCl2), as previously described (Maas et al., 2006).
Mice were sacrificed either at the day of birth (P0) or at adult age
(12–16 weeks old), and their organs were dissected and placed in
an ice-cold IM-Ac buffer. Homogenization was performed using a
Dounce-homogenizer with a teflon pestle for 10 up-and-down
strokes at 1,000 rpm. The homogenates were ultracentrifuged at
150,000g, and the supernatants were discarded. The pellets
were then once more washed in IM-Ac buffer and centrifuged as
described before. The resulting pellets were finally suspended in
appropriate volumes of IM-Ac buffer, and the protein concentra-
tions of the samples were determined using a BCA kit (Pierce,
Bonn, Germany). Samples for SDS-electrophoresis were pre-
pared using Nu-PAGE sample buffer (Invitrogen, San Diego, CA,
USA).
For preparation of membranes of different brain regions, P0,
P7, P14, or P21 mice were decapitated, and their cortex, hip-
pocampus, and cerebellum were dissected in ice-cold phosphate
buffered saline (PBS; 136.9 mM NaCl, 2.68 mM KCl, 1.8 mM
KH2P04, 10 mM Na2HP04, pH 7.4). The samples for SDS-PAGE
ere then prepared in the same way as described for other
issues, using IM-Ac buffer.
For neuronal extracts, cultured neurons were prepared as
reviously described (Maas et al., 2006). Cells were harvested in
ysis buffer (PBS, 1% Triton X-100) supplemented with Complete
ini Protease inhibitor cocktail (Roche, Mannheim, Germany) for
0 min on ice. Lysates were centrifuged at 1,000g for 5 min at
°C, and the supernatant was recovered. Protein concentration
as determined using a BCA assay kit (Pierce, Bonn, Germany).
ubsequently, protein samples were subjected to SDS-PAGE and
estern blotting.
Differential centrifugation
Differential centrifugation was performed as previously described
(Maas et al., 2006). In brief, P10 rats were decapitated, and thebrains were put into a homogenization buffer (320 mM sucrose, 10
mM HEPES/KOH, pH 7.9, 1 mM dithiothreitol, 1 mM EGTA, 1 mM
EDTA) and pottered using a glass-teflon-douncer. Extracts were
centrifuged at 1,000g for 15 min. The resulting pellet was des-
ignated as P1. The supernatant, S1, was further centrifuged at
10,000g for 30 min, and the resulting pellet was named P2. The
remaining supernatant S2 was centrifuged at 100,000g for 1 h,
to obtain pellet P3, with the supernatant referred to as S3. Protein
contents were determined using a BCA protein assay kit (Pierce,
Bonn, Germany).
Specificity of the anti-calumenin antibody
To test whether rabbit anti-calumenin antibody (Cat. Nr
HPA006018, Atlas Antibodies, Stockholm, Sweden) specifically
recognizes calumenin, an antibody-competition experiment was
performed. For that, the coding sequence of calumenin was am-
plified from the whole mouse brain cDNA library (a gift from Han
Kyu Lee, ZMNH), and the resulting PCR product was cloned into
pCMV6-AC vector (Origene, Rockville, MD, USA) using EcoRI
and XhoI restriction sites. The correct sequence of the insert was
confirmed by sequencing at VBC-Biotech Service GmbH, Vienna,
Austria. The pCMV6-AC plasmid DNA encoding for calumenin, or
an empty vector (for mock transfections), were used for transient
transfection of HEK 293 cells, as previously described (Shrivas-
tava et al., 2011). Briefly, HEK 293 cells (CRL 1573; American
Type Culture Collection, Rockville, MD, USA) were grown in Dul-
becco’s Modified Eagle’s Medium (Gibco, Life Technologies,
Carlsbad, CA, USA) supplemented with 10% fetal bovine serum
(BioWhittaker, Lonza, Basel, Switzerland), 2 mM glutamine, 50
M -mercaptoethanol, 100 U/ml penicillin G, and 100 g/ml
treptomycin in 75 cm2 culture dishes using standard cell culture
echniques. HEK 293 cells (3106) were transfected with a total
mount of 15 g of cDNAs using the calcium phosphate precipi-
ation method (Chen and Okayama, 1988). The cells were har-
ested 48 h after transfection. Subsequently, the proteins were
xtracted from the harvested cells by using 1% Triton X-100
ontaining PBS buffer, supplemented with “Complete” protease
nhibitors (Roche, Mannheim, Germany). The anti-calumenin an-
ibodies were incubated for 4 h at 4 °C either with HEK 293 cell
xtract expressing calumenin, or with extract of mock-transfected
EK 293 cells. The mixture of antibodies and the HEK 293 cell
xtract was then added to the blocking buffer (composition described
n sections “Western blotting,” “Immunohistochemistry,” and “Immu-
ocytochemistry” under Experimental procedures, depending on the
pplication) and was used for downstream application—either West-
rn blotting, immunohistochemistry, or immunocytochemistry. Al-
hough there is presumably endogenous expression of calumenin in
uman embryonic kidney cells (as also shown in our experiments for
mbryonic mouse kidney), it could be expected that specific anti-
alumenin antibodies would be blocked to a significantly higher ex-
ent by overexpressed than by endogenous calumenin, resulting in a
ignificant reduction of signal on using these antibodies. Since that
as the case, calumenin was obviously recognized by this antibody.
lthough a possible cross-reactivity of the antibody with an additional
rotein cannot be excluded, it seems to be very unlikely (see “Immu-
ohistochemical distribution of calumenin in P0 and adult mouse
rain,” under Results section).
Western blotting
SDS-PAGE was performed as previously described (Sarto-Jack-
son et al., 2007) using gels containing 10% polyacrylamide in a
discontinuous system. The same amount of protein was applied to
each lane. Proteins were separated on the gels and were then
tank-blotted onto prewetted polyvinylidene fluoride (PVDF) mem-
branes (Millipore, MA, USA). After blocking with 1.5% nonfat dry
milk powder in PBS and 0.1% Tween 20 for 1 h at room temper-
ature, the membranes were incubated overnight with primary
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M. Vasiljevic et al. / Neuroscience 202 (2012) 29–41 31antibodies diluted in blocking buffer at 4 °C. The membranes were
extensively washed and incubated with secondary antibodies (an-
ti-rabbit, or anti-mouse-alkaline phosphatase, F(ab=)2 fragments,
Jackson ImmunoResearch, Suffolk, UK) for 1 h at room temper-
ature. PVDF membranes were again washed extensively as de-
scribed previously and then equilibrated in assay buffer (25 mM
diethanolamine and 1 mM MgCl2, pH 10.0) for 15 min, and sec-
ndary antibodies were visualized by the reaction of alkaline
hosphatase with CDP Star (Applied Biosystems, Bedford, MA,
SA). The chemiluminescent signal was quantified by densitom-
try after exposing the immunoblots to the Fluor-S MultiImager
Bio-Rad) and evaluated using the Quantity One software. The
um of intensities of all specific bands on a blot was assigned
alue 100, and individual band intensities were transformed into
elative numbers accordingly. In agreement with previous reports
Ferguson et al., 2005) it was noticed that the amount of “house-
eeping” proteins such as actin or pan-cadherin changed at dif-
erent time points and in different organs in spite of applying the
ame amount of protein to each lane of the gel. Therefore signals
or actin were only used for normalizing data from the same tissue
nd time point.
Polyclonal rabbit anti-calumenin antibodies were purchased
rom Atlas Antibodies (Cat. Nr HPA006018), Stockholm, Sweden,
nd were used at a dilution of 1:400. Anti-actin antibodies (Sigma,
t. Louis, MO, USA) were used at a dilution of 1:2000. Anti-
SD-95 antibodies (BD Biosciences, San Jose, CA, USA) were
sed at a dilution of 1:250.
Immunohistochemistry
Experiments were performed on three adult C57BL/6 male mice.
The mice were deeply anesthetized and perfused through the
ascending aorta with 0.9% NaCl, followed by a mixture of 4%
paraformaldehyde and 15% picric acid in 0.1 M phosphate buffer
(PB; pH 7.2–7.4). Brains were removed, extensively rinsed in PB,
and serially sectioned in the coronal or sagittal plane on a vi-
bratome at 50 m thickness. Sections were kept in PB containing
.05% sodium azide.
Immunofluorescence experiments were carried out according
o previously published procedures (Klausberger et al., 2003).
riefly, free-floating sections were rinsed in 0.1 M PB and incu-
ated in 0.1% Triton X-100 in PB. Subsequently, the sections
ere blocked by incubation in 20% normal horse serum diluted in
ris-buffered saline (TBS; 50 mM Tris, pH 7.2, 0.85% NaCl) for 2 h
nd transferred into solutions containing mixtures of primary an-
ibodies (rabbit anti-calumenin antibody, Atlas Antibodies, Stock-
olm Sweden, dilution 1:100; mouse monoclonal anti-NeuN anti-
ody, Millipore, MA, USA, dilution 1:1000; mouse monoclonal
nti-calbindin D28k antibody, Marly, Switzerland, dilution 1:10;
hicken polyclonal anti-GFAP antibody, Abcam, Cambridge, UK,
ilution 1:3000; mouse monoclonal PSA-NCAM antibody, Chemi-
on, Millipore, MA, USA, dilution 1:400) for 18–24 h at room
emperature. The next day, sections were washed and incubated
n appropriate secondary antibodies conjugated either with Alexa
luor 488 (anti-rabbit; Invitrogen Molecular Probes, diluted
:1000) or indocarbocyanine (anti-mouse Cy3; Jackson Immu-
oResearch Laboratories Inc., diluted 1:400) for 4 h. All antibodies
ere diluted in TBS containing 0.1% Triton X-100 and 1% normal
orse serum. After washing in 50 mM Tris buffer, pH 7.4, sections
ere mounted in Aqua PolyMount (Polysciences Europe, Eppel-
eim, Germany) and imaged with a Leica TCS SP5 II confocal
icroscope (Leica Microsystems GmbH, Wetzlar, Germany). All
ntibodies were tested for optimal dilution, and secondary anti-
odies were tested for cross-reactivity and non-specific staining.
API nuclear marker was purchased from Invitrogen, San Diego,
A, USA.Immunocytochemistry
Cultured hippocampal neurons were prepared as previously de-
scribed (Maas et al., 2006). In brief, 12 mm sterile glass coverslips
were coated with poly-L-lysin (50 g/ml) and laminin (20 g/ml).
Hippocampi of eight newborn rats (P0) were dissected in PBS/10
mM glucose and subsequently trypsinized for 25 min at 37 °C. The
neurons were then triturated through fire polished Pasteur pipettes of
two different diameters and plated on previously coated and washed
coverslips at a density of about 30.000 cells per cm2 in plating
medium (DMEM/F12, 10% fetal calf serum (v/v), 25 g/ml pyruvate,
mM glutamine, 50 U/ml penicillin, and 50 g/ml streptomycin). The
cells were grown for 3–5 h at 37 °C and 5% CO2. At this time point,
the plating medium was replaced with 1 ml neuronal culture medium
(Neurobasal medium, 25 g/ml pyruvate, 2 mM glutamine, 50 U/ml
enicillin, 50 g/ml streptomycin, 2% B27 supplement (v/v)). At days
in vitro (DIV) 12–14, the neurons were fixed in 4% paraformalde-
hyde/4% sucrose for 12 min. Subsequently, the cells were washed
with PBS and permeabilized with 0.25% Triton X-100 containing PBS
buffer for 4 min. Unspecific binding sites were blocked with 1% (w/v)
bovine serum albumin (Applichem, Darmstadt, Germany) in PBS
(blocking buffer). Primary antibodies were applied in blocking buffer
overnight at 4 °C, as previously described (Tagnaouti et al., 2007).
The following primary antibodies were used: anti-KDEL (Stressgen,
Ann Arbor, MI, USA) dilution 1:100, anti-GM 130 (BD Biosciences,
Franklin Lakes, NJ, USA) dilution 1:100, anti-synaptophysin (Synap-
tic Systems, Göttingen, Germany) dilution 1:1000. Application of
secondary antibodies was carried out in the blocking buffer, after
washing of coverslips with PBS. Anti-rabbit-Alexa488 antibody (In-
vitrogen, San Diego, CA, USA) was applied at dilution 1:200, anti-
guinea pig-Cy3 (ImmunoResearch Laboratories, Inc, West Grove,
PA, USA) at dilution 1:500, and anti-mouse-Cy3 secondary antibod-
ies (Jackson ImmunoResearch Laboratories, Inc, West Grove, PA,
USA) at dilution 1:500. Fluorescence imaging was carried out with an
inverted Leica TCS-SP5 II laser scanning confocal microscope. For
simultaneous multichannel fluorescence, images were taken in a
sequential channel recording mode.
Statistical analysis
Statistical analysis was performed using GraphPad Prism software
(GraphPad Software, Inc., La Jolla, CA, USA). The normality of the
distribution of values within each group was tested by the Kolmogo-
rov–Smirnov normality test. As the normal distribution of values was
confirmed, the differences in signal intensities in Western blots were
analyzed using parametric Student’s unpaired t-test. For P0.05 (*)
ifference was designated as statistically significant, whereas
0.01 represented highly significant difference (**).
RESULTS
Distribution of calumenin transcripts in mouse brain
during development
To analyze calumenin mRNA distribution in the developing
mouse CNS, a radioactive probe corresponding to calu-
menin nucleotides 1529–2355 was used (Fig. 1A). At em-
bryonic day 12 (E12), a moderate hybridization signal in
the developing CNS (Fig. 1B) as well as in other tissues:
bones, skin, heart, lung, and muscles was observed (data
not shown). At E12–E20 considerable levels of calumenin
transcripts were observed in the neuroepithelium of the
cortex, in cerebellum, as well as the brain stem (medulla
oblongata, pons, and midbrain). Higher than average sig-
nal intensity was observed in the regions around aqueduct,
fourth ventricle, and lateral ventricle (arrows), the regions
representing germinal zones containing migrating neurons
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M. Vasiljevic et al. / Neuroscience 202 (2012) 29–4132and glia cells (Hatten, 1999). Specificity of in situ hybrid-
ization signals was controlled by using a sense transcript
of the same cDNA probe used for hybridization.
Subsequently, in situ hybridization of mouse brain tis-
sue derived from different postnatal stages (P) (P7, P14,
and adult) was performed. A basal expression of calu-
menin mRNA was visible throughout the brain (Fig. 1C).
Higher signal intensities were observed in the cerebellum,
the hippocampal formation, the thalamus, the olfactory
bulb, and the cortex of both P7 and P14 mice (Fig. 1C,
A
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Fig. 1. Schematic representation of mRNA and protein domains in calum
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robe on E12 (upper panel) or E16 mouse embryo (lower panel). Negativ
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erebellum, and the brain stem. (C) Representative micrographs of X-ray
nd P14 and of the adult mouse brain. The specific signal for calumenin m
nd the olfactory bulb of both P7 and P14 mice (arrows). The intensity of th
sense RNA probe; the signal of unspecific hybridization was similar for P
erebellum; Cx, cortex; HC, hippocampus; LV, lateral ventricle; MB, mi
nterpretation of the references to color in this figure legend, the reader iarrows). However, the overall specific signal intensity de-creased with age (Fig. 1C, adult), as compared with sig-
nals of the sense control. These data indicate that calu-
menin transcripts are well expressed in the second half of
mouse embryonic development, suggesting that calu-
menin plays a role in early developmental stages.
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M. Vasiljevic et al. / Neuroscience 202 (2012) 29–41 33conditions (Tyedmers et al., 2005; Jung et al., 2006; Cho et
al., 2009; Honoré, 2009; Westergaard Hansen et al.,
2009). To investigate its distribution during development,
the specificity of the anti-calumenin antibody used in this
study was tested as a first step. The anti-calumenin anti-
body alone (data not shown), or pre-incubated with ex-
tracts of mock-transfected HEK 293 cells (Fig. 2A) labeled
a single protein band with apparent molecular mass of 45
kDa (Sahoo and Kim, 2008; Sahoo et al., 2009) in HEK
293 cells transfected with recombinant calumenin or in P0
brain membranes. In untransfected (data not shown) or
mock-transfected HEK 293 cells, a protein band with the
same molecular mass was only weakly labeled, probably
representing endogenous calumenin. This small amount of
endogenous calumenin was obviously not sufficient to sig-
nificantly reduce the labeling of these proteins by the anti-
calumenin antibody. In contrast, staining of this protein
band was no longer observed either in mock-transfected or
calumenin-transfected HEK 293 cells, or in P0 brain mem-
branes (Fig. 2A), when the antibody was pre-adsorbed by
extracts of calumenin-transfected HEK 293 cells. These
data indicate that the observed 45 kDa protein represented
calumenin.
To assess the amount of calumenin protein in various
tissues compared with its relative expression in brain, the
same amount of membrane protein from mouse brain,
heart, kidney, lung, and stomach of P0 and adult animals
was subjected to SDS-PAGE and immunoblotting. As
shown in Fig. 2B, the calumenin levels were significantly
higher in P0 mice than in adult mice in all tissues investi-
gated.
As a next step, the levels of calumenin in three different
brain regions (cerebellum (Cb), cortex (Cx), and hip-
pocampus (Hip)) were assessed during early postnatal
development (P0, P7, P14, and P21, Fig. 3). Data obtained
indicated a decreased expression of calumenin at the end
of the third postnatal week in all tissues investigated. Over-
all, these data are consistent with the in situ hybridization
ata (Fig. 1) and suggest that calumenin protein levels
radually decrease from early postnatal development to
dulthood.
mmunohistochemical distribution of calumenin in
0 and adult mouse brain
o investigate the distribution of calumenin in the mouse
rain, we performed immunostaining of fixed sagittal and
oronal sections of either P0 or adult mouse brain tissue.
lthough the signal for calumenin in adult hippocampus
as lost upon pre-adsorption of the antibody with over-
xpressed calumenin from the HEK 293 cell extracts (Fig.
A), the same antibody could still recognize its target upon
ncubation with the extract of mock-transfected HEK 293
ells (Fig. 4B, arrows). In addition, the distribution of the
alumenin protein in P0 and adult brain, for instance in
erebellum and around the lateral ventricle, was similar to
hat observed for calumenin mRNA (Fig. 1). Finally, the
estricted distribution of calumenin in adult brain tissue
Fig. 4H–Q) indicates that the antibody used specifically
inds to its target. Although a crossreactivity of the anti- aody with another protein cannot be completely excluded,
ll our data suggest that such a crossreactivity is highly
nlikely.
As depicted in Fig. 4C, the signal intensity for calu-
enin in cerebral cortex, cerebellar cortex, mitral cell layer
f olfactory bulb, and migrating cells in the germinal zones
Fig. 2. Distribution of calumenin in different tissues of newborn (P0)
and adult mice. (A) Western blots showing specificity of the anti-
calumenin antibody. In the upper panel, antibodies preadsorbed by
extracts of mock-transfected HEK 293 cells were used for immuno-
staining of extracts of mock-transfected HEK 293 cells, calumenin-
transfected HEK 293 cells, as well as P0 brain membranes. In the
lower panels immunostaining for calumenin was lost or strongly re-
duced in all lanes when the anti-calumenin antibody was preadsorbed
by extracts of calumenin-transfected HEK 293 cells. (B) Western blots
showing calumenin levels in different organs in P0 vs. adult animals.
The same amount of protein was applied to each lane, and the signal
of each band was normalized to the sum of intensities of bands in all
lanes. Calumenin expression in brain, heart, kidney, lung, and stom-
ach of P0 mice was significantly higher than in adult mice (values are
given as meanstandard error of mean (SEM): brain P0 vs. adult:
8.30.8 vs. 3.61.1; heart P0 vs. adult: 13.01.1 vs. 4.70.5; kidney
P0 vs. adult: 21.01.5 vs. 6.60.9; lung P0 vs. adult: 12.81.0 vs.
9.51.0; stomach P0 vs. adult: 14.31.6 vs. 6.51.2). The experi-
ment was independently performed three times, each time using a
different P0 and adult animal pair. In addition, three Western blots
were done for each animal pair. Asterisk (*) represents statistically
significant difference; *P0.05, **P0.01. a.u., arbitrary units; Ab,
antibody; WB, Western blot.round the lateral ventricle of P0 mice was higher than in
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M. Vasiljevic et al. / Neuroscience 202 (2012) 29–4134other brain regions. As seen in higher magnification (Fig.
D), calumenin immunoreactivity could be observed in cell
odies of immature migrating cells around the lateral ven-
ricle in P0 mice (arrows in Fig. 4D).
After immunohistochemical staining of sagittal sections
f adult mouse brains with anti-calumenin antibody, a mod-
rate signal was detected in all brain regions (Fig. 4E).
owever, a significant immunoreactivity was observed in
lfactory tract, thalamic nuclei and Purkinje cell layer (PCL,
ig. 4E, F, arrowhead), and deep nuclei of cerebellum (Fig.
F, arrow). By using confocal microscopy on sagittal (Fig.
G) and coronal (Fig. 4H–J) cerebellar sections, individual
alumenin-positive cells (stained in green) were detected
n the granule cell layer (crossed arrow in Fig. 4H) and
olecular layer (asterisk in Fig. 4H). These cells did not
xpress post-mitotic neuronal marker NeuN (Fig. 4H, I,
ed). The majority of calumenin-positive cells in cerebellum
ere situated in the PCL (arrows in Fig. 4G–J), between
arge cell bodies of Purkinje neurons. Purkinje neurons,
owever, did not show calumenin staining (arrowheads in
H, I). Given that calumenin-positive cells in PCL (green)
ere negative for NeuN and also for calbindin D28k, a
urkinje neurons-marker (Fig. 4J, red), these cells most
robably represent glia. Morphologically, they resemble
Fig. 3. Calumenin expression in different brain regions during post-
natal development. Representative blots depicting changes of expres-
sion levels of calumenin in different brain regions in the first three
postnatal weeks. Equal amounts of protein from three independent
experiments were blotted to the membrane, and the signal of each
band was normalized to the sum of intensities of bands in all lanes.
Calumenin levels in cerebellum, cortex, and hippocampus, tend to
decrease in the third postnatal week (Cb: P0, 11.82.9; P7, 12.02.4;
P14, 11.10.9; P21, 7.91.3; Cx: P0, 8.70.6; P7, 10.51.6; P14,
8.50.6; P21, 5.70.5; Hip: P0, 7.91.7; P7, 9.92.2; P14, 5.90.6;
P21, 2.91.1). The experiment was independently performed three
times. For each experiment different animals were used, one for each
time point. Three Western blots were done per each experiment.
Asterisk represents statistically significant differences (P0.05). Key:
Cb, cerebellum; Cx, cortex; Hip, hippocampus; n.s., non-significant.ergman glia cells, specialized cerebellar astrocytes hav- Ting somata localized in PCL and extensions propagating
throughout molecular layer (Fig. 4G, J, red arrowheads).
A population of calumenin-expressing individual cells
could also be observed in the olfactory bulb (Fig. 4K,
arrowhead), mostly at the border between the mitral cell
body layer and the external plexiform layer. Some large
neurons in pons also express calumenin (arrow in Fig. 4L),
as well as some small NeuN-negative cells (arrowhead in
Fig. 4L).
In coronal sections of dentate gyrus of adult mouse
individual NeuN-negative cells expressing calumenin
could be detected in the molecular layer as well as in the
polymorphic layer of dentate gyrus (Fig. 4M, arrowheads).
However, we detected a large population of calumenin-
expressing cells (stained in green) in the basal part of the
granule cell layer and in the subgranular zone (SGZ) (ar-
row in Fig. 4M). As the subgranular zone is one of two well
established zones of adult neurogenesis (Schaar and Mc-
Connell, 2005), calumenin-positive cells in this region that
do not express NeuN marker could be either mature glia or
undifferentiated progenitor cells. To investigate whether
calumenin-positive cells in SGZ of dentate gyrus also ex-
press the markers of neuronal progenitor cells and/or im-
mature neurons, coronal sections of dentate gyrus were
stained with glial fibrillary acidic protein (GFAP), a marker
of astrocytes and proliferating and differentiating progeni-
tor cells (von Bohlen und Halbach, 2007), as well as with
PSA-NCAM, a marker of differentiating and migrating neu-
rons in adult dentate gyrus (Kronenberg et al., 2003). As
depicted in Fig. 4N (arrows), some of calumenin-express-
ing cells in SGZ expressed also GFAP (red). In addition,
we could also detect calumenin-positive cells that co-ex-
pressed PSA-NCAM (red, Fig. 4O, arrows). Since GFAP
and PSA-NCAM are no longer present in differentiated
mature neurons, this indicates that the cells in SGZ co-
expressing calumenin and these markers most probably
represent differentiating and migrating progenitor cells.
Moreover, some astrocytes in the granule cell layer and
molecular layer of dentate gyrus are also positive for calu-
menin, as seen by its co-expression with GFAP (Fig. 4N,
arrowheads). Some of the calumenin-positive cells in SGZ
and at the border between the granule cell layer and the
molecular layer were also weakly positive for NeuN
(stained in red in Fig. 4M, P, Q), indicating that they might
represent differentiated interneurons (arrow in Fig. 4P and
the boxed cell in Fig. 4P that is enlarged in Fig. 4Q). Taken
ogether, in the dentate gyrus of mouse hippocampus,
alumenin seems to be expressed by glia cells, postmitotic
eurons as well as by undifferentiated progenitor cells.
Overall, the immunohistochemical analysis of adult
ouse brain indicates that calumenin is expressed in dif-
erent brain regions and in individual cells that can belong
o diverse neuronal and non-neuronal cell types.
ubcellular distribution of calumenin upon
ifferential centrifugation of whole brain extracts
n non-neuronal cells of rodents, calumenin has been re-
orted to associate with ER membranes (Yabe et al., 1997;
yedmers et al., 2005; Sahoo and Kim, 2008, 2010; Sahoo
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Fig. 4. Tissue distribution of calumenin protein in brain sections of newborn (P0) and adult mice. (A) Coronal section of the hippocampal dentate gyrus
stained with anti-calumenin antibody pre-adsorbed by extracts of calumenin-transfected HEK 293 cells, showing no signal. (B) Coronal section of the
hippocampal region stained with anti-calumenin antibody pre-adsorbed by extracts of mock-transfected HEK 293 cells, showing specific signal in
individual cells of subgranular zone and granule cells layer of the dentate gyrus (arrows). (C) Whole brain sagittal section of a P0 mouse brain stained
with anti-calumenin antibody. Calumenin displays widespread moderate protein expression with higher signal intensity in cerebellum (Cb), cortex (Cx),
olfactory bulb (BO), and migrating cells (MC) around lateral ventricle. (D) Confocal image of the region around the lateral ventricle of P0 mouse brain.
High immunoreactivity of calumenin is detected in migrating cells and radial-like glia around the lateral ventricle (arrows). (E) Whole brain sagittal
section of an adult mouse brain stained with anti-calumenin antibody. Calumenin protein is moderately expressed throughout the brain. The strongest
signal intensity is detected in cerebellum (Cb), olfactory tract (TBO), and thalamic nuclei (Th). (F) Stereomicroscopic image of calumenin immuno-
reactivity in adult mouse cerebellum. The highest expression of calumenin is visible in Purkinje cell layer (arrowhead) and deep nuclei of cerebellum
(arrow). (G) Confocal image of a sagittal adult mouse cerebellar section co-stained for calumenin (green) and a nuclear marker DAPI (blue). The
immunoreactivity of calumenin is strongest in PCL (arrow). Some of calumenin-positive cells of PCL send their extensions throughout the molecular
cell layer, which is a morphological characteristic of Bergman glia cells (red arrowhead). (H) Confocal image of coronal cerebellar cortex section
stained for calumenin (green) and NeuN (red), a postmitotic neuronal marker. The cells in PCL having the strongest signal intensity for calumenin are
NeuN-negative (arrow). There are also individual NeuN-negative cells in ML (asterisk) and GCL (crossed arrow) that are moderately positive for
calumenin. The arrowhead indicates a large body of a Purkinje cell. (I) Enlarged image of the boxed region from (H)—a group of cells strongly
expressing calumenin (arrow) next to the large calumenin-negative cell body of Purkinje cell (arrowhead). (J) Confocal image of cerebellar cortex;
calumenin (green), calbindin D28k (red). Calumenin is expressed by cells in PCL (arrow) that send their extension through ML (red arrowhead), which
is typical for Bergmann glia. Purkinje cells express calbindin D28k, but no calumenin. (K) Olfactory bulb. A sagittal section was stained for calumenin
(green) and nuclear marker DAPI (blue). Individual cells in external plexiform layer are moderately positive for calumenin (arrowhead). (L) Coronal
section of pons. Calumenin (green) and NeuN (red) colocalize in individual large neuronal cell bodies (arrow), but there are also NeuN-negative small
cells expressing calumenin (arrowhead). (M) Coronal section of the dentate gyrus co-stained for calumenin (green) and NeuN (red). In the basal part
of granule cell layer (DGL) there are both NeuN-positive and negative cells of diverse morphology strongly stained for calumenin (arrow). In molecular
(DML) and polymorphic layer (PoDG) however, there are only small, individual NeuN-negative cells expressing calumenin (arrowheads). (N)
Co-staining of dentate gyrus for calumenin (green) and glial fibrillary acidic protein (GFAP), a marker of astrocytes and neuronal progenitor cells (red).
Arrows point to calumenin-positive cells in subgranular zone that co-express GFAP, whereas arrowheads point to astrocytes in DGL and DML, also
expressing calumenin. (O) Co-staining of dentate gyrus for calumenin (green) and PSA-NCAM, early neuronal marker (red). Some of calumenin-
positive cells in subgranular zone also express PSA-NCAM (arrows). (P) Image of a dentante gyrus section stained for calumenin (green) and NeuN,
a postmitotic neuronal marker (red). Arrow points at a large cell in subgranular layer expressing both calumenin and NeuN (weak expression). One
cell expressing both proteins is depicted in boxed region at the border between DGL and DML. (Q) Enlarged image of the cell in the boxed region from
(P). Arrow points to a weak NeuN signal in the nucleus, whereas arrowhead represents the somatic calumenin staining. Key: BO, olfactory bulb; Cb,
cerebellum; Cx, cortex; DG, dentate gyrus; DGL, granule cell layer of dentate gyrus; DML, molecular layer of dentate gyrus; GR, granule cell layer of
olfactory bulb; EP, external plexiform layer; GCL, granule cell layer of cerebellum; HC, hippocampus; LV, lateral ventricule; MB, mitral cell body layer;
MC, migratory cells; ML, molecular layer of cerebellum; Ps, pons; PCL, Purkinje cell layer; TBO, olfactory tract; Th, thalamus; PoDG, polymorphic layer
of dentate gyrus. Scale bars: (A, B) 50 m, (C) 1 mm, (D) 0.5 mm, (E, F) 1 mm, and (G–P) 50 m.
. (Contin
M. Vasiljevic et al. / Neuroscience 202 (2012) 29–4136et al., 2009). To investigate whether calumenin co-local-
izes with membrane structures of neuronal tissue, a differ-
ential centrifugation of adult rodent whole brain lysates
was performed. Immunoblotting of individual subcellular
fractions revealed strong signals representing calumenin
in lanes containing the P1 pellet, which consists of nuclei
and remaining intact cells (data not shown). Furthermore,
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menin (Fig. 5). In contrast, smaller amounts of calumenin
were detected in the supernatants S2 and S3 representing
the cytoplasmic fractions typically enriched in soluble pro-
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M. Vasiljevic et al. / Neuroscience 202 (2012) 29–41 37subcellular fractionation (Lee, 2001) and is known to be
nriched in P2 fractions (Kennedy, 1997) and intracellular
argo vesicles (P3) (Mok et al., 2002).
ubcellular localization of calumenin in hippocampal
ell culture
t has been reported previously that calumenin is pres-
nt throughout the secretory pathway of some mamma-
ian cells (Vorum et al., 1999). To study the subcellular
ocalization of calumenin in hippocampal cell cultures, it
as important to investigate whether the developmental
hanges of calumenin levels in culture were similar to
hose observed in vivo. As shown in Fig. 6A, a continu-
ous decrease in calumenin levels was observed over
time ranging from DIV 3 to DIV 11. This is in accordance
with our biochemical results from brain tissue and shows
an overall tendency for a decrease of calumenin expres-
sion over time.
Subsequently cultured rat hippocampal cells at DIV
12–14 were co-stained with antibodies against calumenin
and different subcellular markers. Control experiments in-
dicated that the anti-calumenin antibody pre-adsorbed by
over-expressed calumenin (Fig. 6B, left), in contrast to
mock-adsorbed antibody (Fig. 6B, right, arrows), did not
detect its target anymore. This again demonstrated the
specificity of the calumenin signal obtained.
As depicted in Fig. 6C–E, the highest calumenin im-
Fig. 5. Calumenin distribution in whole brain cell extracts upon differ-
ential centrifugation. (A) Calumenin is abundant in the plasma mem-
brane fraction (P2) and supernatant S1, containing remaining mem-
branes and the cytoplasm, respectively. Further separation reveals
relatively high enrichment of calumenin in fraction P3, representing
vesicular membranes. In contrast, the soluble fraction S3 contains little
calumenin. Detection of actin was used as a loading control, and
PSD-95, which is known to be enriched at postsynaptic sites (P2) and
at intracellular transport vesicles, is shown as a positive control. (B)
The amounts of calumenin per fraction were quantitatively evaluated
from three independent experiments (S1, 0.310.18; P2, 0.290.13;
S2, 0.140.02; P3, 0.580.22; S3, 0.090.02). Data were normalized
against the respective actin signal, representing the relative amount of
protein per lane. a.u., arbitrary units.munoreactivity (shown in green) was observed in the so-matic region of the cells. To investigate whether the pre-
viously reported association of calumenin with the ER and
within secretory pathway routes overlaps with the subcel-
lular distribution of calumenin in hippocampal cells, a pos-
sible co-localization of calumenin with markers for the ER
and Golgi was analyzed. Prominent levels of co-localiza-
tion of calumenin with the ER were observed, as shown by
co-staining with anti-calumenin and anti-KDEL antibodies
(Fig. 6C, arrows showing the co-localization in enlarged
boxed region). Counterstaining of calumenin with the Golgi
marker GM 130 revealed a localized overlapping of the
analyzed signals (Fig. 6D, arrows in enlarged boxed re-
gion), suggesting that calumenin can be transported from
the ER to the Golgi cisternae, as previously reported for
other tissues (Vorum et al., 1999; Honoré and Vorum,
2000; Honoré, 2009). In contrast, calumenin did not signif-
icantly co-localize with the presynaptic marker synapto-
physin (Fig. 6E), or with some other markers of synaptic
sites: pre-synaptic marker SV2, marker of post-synaptic
excitatory sites (PSD-95), and marker of inhibitory post-
synaptic sites (Gephyrin) (data not shown). The HDEF
sequence of calumenin has previously been described as
an ER retention signal; accordingly, the immunocytochem-
ical data show that most of calumenin resides in the ER of
hippocampal cells, whereas only a small amount can be
transported to Golgi cisternae. No synaptic localization of
calumenin could be demonstrated.
DISCUSSION
In the present study the expression of the Ca2-binding
protein calumenin in rodent CNS was analyzed. Protein
levels of calumenin in brains of both P0 and adult mice are
comparable with levels in heart, lung, and stomach. Calu-
menin mRNA transcript expression occurs throughout the
CNS of P0 mice and decreases with age to reach a low
expression level in adult mice. A similar decline in calu-
menin expression can also be observed in hippocampal
cell cultures in vitro over time. In accordance with our in
situ hybridization data, immunohistochemical stainings of
P0 mice revealed a moderate expression of calumenin
throughout the brain, with the highest signal intensity in
cells situated in the area around the lateral ventricle - in
germinal zones containing multipotent neural stem cells
and radial glia (Hatten, 1999; Parnavelas, 2000; Wichterle
et al., 2001). Cells in these zones represent migrating
neurons, which are born in neocortical ventricular zone
and probably give rise to the principal pyramidal neurons of
the neocortex (Sidman and Rakic, 1973; Parnavelas,
2000; Walsh and Goffinet, 2000). It has been well docu-
mented that intracellular calcium and calcium-binding pro-
teins play a key role in many processes during the devel-
opment of the central nervous system, including cell divi-
sion, neuronal migration, and cell movement (Kwong et al.,
2000; Konur and Ghosh, 2005; Berglund and Augustine,
2008). Notably, calumenin was described in functional as-
sociation with the cytoskeleton in HeLa cells and fibro-
blasts (Ostergaard et al., 2006; Bull et al., 2010). Cytoskel-
eton on the other hand plays an essential role in neuronal
M. Vasiljevic et al. / Neuroscience 202 (2012) 29–4138movements during migration (Schaar and McConnell,
Fig. 6. Calumenin localization at the subcellular level in primary
hippocampal cell culture from 18 h after plating to DIV 11. The sa
decrease over time in vitro. (B) Hippocampal cell culture showing no
of calumenin-transfected HEK 293 cells (left panel) and positive
mock-transfected HEK 293 cells (right panel, arrows). (C–E) Cultur
markers for different subcellular compartments (red). Calumenin m
extensions to a much lower extent. (C) Calumenin highly co-localiz
partially co-localizes to Golgi marker GM 130 (arrows in enlarged b
calumenin. Scale bars: (B) 50 m and (C, D, E) 15 m.2005). Taken together, these data indicate a possible im-
portant role of calumenin in migration and differentiation of
pal culture. (A) Expression of calumenin during development in
unt of protein was applied to each lane. Calumenin levels tend to
pon staining with anti-calumenin antibody pre-adsorbed by extracts
of cells with calumenin antibody pre-adsorbed with extracts of
campal cells were co-stained for calumenin (green) and individual
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rain, distinct populations of cells expressing calumenin
ould be detected. In cerebellum, the majority of cells
tained for calumenin were situated in the PCL, and they
ost probably represent Bergmann glia cells. Calcium
ignaling plays a key role in regulating structural and func-
ional interactions between Bergmann glia and Purkinje
ell synapses (Metea and Newman, 2006). Calumenin
ould thus be one of the proteins involved in Ca2 homeo-
stasis of Bergmann glia cells. In dentate gyrus of hip-
pocampus, individual NeuN-positive cells at the border
between granule cell layer and molecular layer, as well as
in subgranular zone, also express calumenin and most
probably represent interneurons. However, most of the
calumenin-positive cells in dentate gyrus were not stained
with NeuN, suggesting that they might represent glia. This
was confirmed by co-staining of a population of cells in
dentate gyrus with calumenin and astrocytic marker GFAP.
Calcium signaling exerts important effects on glia homeo-
stasis. In astrocytes, for example, calcium signaling is not
restricted to single cells but can cross cell borders via gap
junctions, resulting in intracellular Ca2 waves traveling
from one glia cell to the next, or in the induction of Ca2
responses in neurons (Verkhratsky, 1997). Calcium signal-
ing might thus represent a form of glial excitability, en-
abling these cells to integrate extracellular signals, com-
municate with each other, and exchange information with
neurons. Interestingly, most of NeuN negative cells ex-
pressing calumenin were localized in the SGZ of dentate
gyrus, one of two well established regions where adult
neurogenesis takes place (Ming and Song, 2005). More-
over, some of these calumenin-positive cells were also
expressing GFAP, the marker of progenitor cells and as-
trocytes, whereas some cells co-expressed calumenin with
PSA-NCAM, the marker of differentiating and migrating
progenitor cells (Kronenberg et al., 2003; von Bohlen und
Halbach, 2007). Taken together, these immunohistochem-
ical data strongly indicate that calumenin can be ex-
pressed by progenitor cells situated in SGZ of dentate
gyrus and that it might play a role in early stages of adult
neurogenesis.
Finally, on the subcellular level, calumenin was most
abundant in membrane-enriched fractions obtained upon
differential centrifugation of rat brain. Furthermore, a high
immunoreactivity of calumenin was observed in the so-
matic region of cultured rat hippocampal cells where it
co-localized with markers for ER and Golgi apparatus. It
has been reported previously that calumenin harbors a
weak ER-retention signal HDEF at its C-terminus (Yabe et
al., 1997; Vorum et al., 1999). In addition, calumenin ex-
hibits a low affinity for Ca2 (Honoré and Vorum, 2000),
which suggests that it might have especially important
functions under conditions of relatively high Ca2 concen-
rations, as in the ER. Taken together, this indicates that
alumenin might exhibit at least part of its functional effects
t the ER level of neuronal and/or glia cells. Two possible
unctions of ER Ca2-binding proteins have been sug-
gested: first, protein folding and protein sorting (Wikström
and Lodish, 1993; Wada et al., 1995; McCormick, 1995)and second, regulation of Ca2 capacity of ER and Ca2
flow therein (Lodish and Kong, 1990; Bastianutto, 1995).
Functional associations of calumenin with members of the
ER Ca2-ATPases and ryanodine receptors in cardiomy-
cytes suggest a role in control of Ca2 flux between
cytoplasm and intraorganellar Ca2-stores. Further analy-
ses are needed to establish the presence and importance
of such interactions of calumenin in the CNS.
A variety of synaptic markers (synaptophysin, SV2,
PSD-95, and gephyrin) were used together with anti-calu-
menin antibody, to test whether calumenin could be found
at synaptic sites. Using confocal microscopy, a significant
co-localization of calumenin and the above mentioned syn-
aptic markers could not be observed. However, to defi-
nitely exclude the presence of calumenin in those parts of
the ER being in close proximity of synaptic sites (Ramírez
and Couve, 2011), a much higher resolution such as that of
electron microscopy would be required.
Increased calcium concentration is observed not only
under normal conditions in Ca2-storing organelles and in
he extracellular space, but is also a hallmark of diverse
europathological conditions, such as neurodegeneration
Mattson, 2007; Sammels et al., 2010; Supnet and Bez-
rozvanny, 2010; Surmeier et al., 2010). The role of vari-
us Ca2-binding proteins in neurodegeneration in both
neuronal and glia cells has been well studied (Heizmann
and Braun, 1992; Verkhratsky, 1997; Gómez-Tortosa et
al., 2001; Nedergaard et al., 2010). Interestingly, calu-
menin has been demonstrated to associate with serum
amyloid P component (Vorum et al., 2000), a member of
the pentraxin family of plasma proteins, which is up-regu-
lated in neurons of humans with Alzheimer disease (Ya-
sojima, 2000). Future investigations should answer
whether this interaction also takes place in the CNS and
what the functional implications of such association are.
The present data establish a starting point for further
analysis of the calcium-binding protein calumenin in the
rodent brain. Due to its possible role in neuronal develop-
ment and in Ca2-signaling between different cell types of
he CNS, it might have an important function in health and
isease.
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